Integer Holdings Corp. (ITGR)
90.44
+0.47
(+0.52%)
USD |
NYSE |
May 19, 16:00
90.46
+0.02
(+0.02%)
Pre-Market: 20:00
Integer Holdings Research and Development Expense (Quarterly) : 16.09M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 361.60M |
| LeMaitre Vascular, Inc. | 4.06M |
| QuidelOrtho Corp. | 44.90M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |